Consequently, in our current study, we aim to investigate whether KPF treatment has therapeutic effects on type-2 DN model of db/db mice and to examine the mechanism underlying the protective effects of KPF on DN by focusing on the regulation of podocyte autophagy via AMPK/mTOR pathway. The gene discussed is MTOR; the disease is liver dysplastic nodule.